46 results on '"Meng, Tinghua"'
Search Results
2. Comparison of [68Ga]Ga-FAPI and [18F]FDG uptake in patients with gastric signet-ring-cell carcinoma: a multicenter retrospective study
3. Acute Appendicitis Complicated by Septic Thrombophlebitis of the Portal Vein Shown by 18F-FDG and 68Ga-FAPI-46 PET/CT
4. Visualization of Intermetastatic Heterogeneity in Mixed Neuroendocrine Carcinoma–Acinar Adenocarcinoma of the Prostate by 68Ga-PSMA, 68Ga-FAPI, and 18F-FDG PET/CT
5. 68Ga-FAPI Versus 18F-FDG PET/CT in the Evaluation of Epithelioid Hemangioendothelioma of Bone
6. Positron emission tomography and computed tomography with [68Ga]Ga-fibroblast activation protein inhibitors improves tumor detection and staging in patients with pancreatic cancer
7. 68Ga-FAPI PET/CT Detected Non–PSMA/FDG-Avid Primary Tumor in De Novo Metastatic Prostate Cancer
8. Serous Cystadenoma of the Pancreas Showing Increased Uptake on 68Ga-FAPI PET/CT
9. Differentiation of Reactive Lymph Nodes and Tumor Metastatic Lymph Nodes With 68Ga-FAPI PET/CT in a Patient With Squamous Cell Lung Cancer
10. 68Ga-FAPI PET/CT detected non-FDG-avid bone metastases in breast cancer
11. 18F-FDG Versus 68Ga-FAPI PET/CT in Visualizing Primary Hepatic Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue
12. 68Ga-DOTATATE PET/CT in Primary Pulmonary Lymphoepithelioma-Like Carcinoma
13. [68Ga]Ga-FAPI PET/CT imaging of brown tumors in a patient with primary hyperparathyroidism
14. Increased [68 Ga]Ga-FAPI uptake in focal nodular hyperplasia in a patient with sigmoid colon cancer
15. SSTR antagonist [68Ga]Ga-DOTA-LM3 differentiates intrapancreatic accessory spleen from neuroendocrine tumor in a patient presenting indeterminate MRI and SSTR agonist [68Ga]Ga-DOTATATE
16. Gallium-68-Labelled Fibroblast Activation Protein Inhibitor PET/CT in the clinical diagnosis and management of breast cancer: Comparison with [18F]FDG PET/CT
17. PET Imaging of Fibroblast Activation Protein in Various Types of Cancer Using68Ga-FAP-2286: Comparison with18F-FDG and68Ga-FAPI-46 in a Single-Center, Prospective Study
18. Comparison of [68Ga]Ga-FAPI and [18F]FDG uptake in patients with gastric signet-ring-cell carcinoma: a multicenter retrospective study
19. SSTR antagonist [68Ga]Ga-DOTA-LM3 differentiates intrapancreatic accessory spleen from neuroendocrine tumor in a patient presenting indeterminate MRI and SSTR agonist [68Ga]Ga-DOTATATE.
20. Epiglottic Polymorphous Adenocarcinoma With Multiple Bone Metastases Detected by 68Ga-FAPI PET/CT
21. Comparison of [68Ga]Ga-FAPI and [18F]FDG uptake in patients with gastric signet-ring-cell carcinoma: a multicenter retrospective study.
22. Uncommon Metastases From Occult Breast Cancer Revealed by 18F-FDG and 68Ga-FAPI PET/CT
23. Visualization of Intermetastatic Heterogeneity in Mixed Neuroendocrine Carcinoma–Acinar Adenocarcinoma of the Prostate by 68 Ga-PSMA, 68 Ga-FAPI, and 18 F-FDG PET/CT.
24. [68Ga]Ga-FAPI PET/CT imaging of brown tumors in a patient with primary hyperparathyroidism
25. 68 Ga-FAPI PET/CT Detected Non–PSMA/FDG-Avid Primary Tumor in De Novo Metastatic Prostate Cancer.
26. Serous Cystadenoma of the Pancreas Showing Increased Uptake on 68 Ga-FAPI PET/CT.
27. Epiglottic Polymorphous Adenocarcinoma With Multiple Bone Metastases Detected by 68 Ga-FAPI PET/CT.
28. Positron emission tomography and computed tomography with [68Ga]Ga-fibroblast activation protein inhibitors improves tumor detection and staging in patients with pancreatic cancer
29. 68Ga-Exendin-4 PET/CT Differentiates Insulinoma From Accessory Spleen in a Patient Presenting Indeterminate MRI and 68Ga-DOTATATE PET/CT Findings
30. 68 Ga-FAPI Versus 18 F-FDG PET/CT in the Evaluation of Epithelioid Hemangioendothelioma of Bone.
31. 68Ga-DOTATATE PET/CT in Primary Pulmonary Lymphoepithelioma-Like Carcinoma
32. Differentiation of Reactive Lymph Nodes and Tumor Metastatic Lymph Nodes With 68Ga-FAPI PET/CT in a Patient With Squamous Cell Lung Cancer.
33. 18F-FDG and 68Ga-FAPI PET/CT in the Evaluation of Ground-Glass Opacity Nodule
34. Positron emission tomography and computed tomography with [68Ga]Ga-fibroblast activation protein inhibitors improves tumor detection and staging in patients with pancreatic cancer.
35. Uncommon Metastases From Occult Breast Cancer Revealed by 18 F-FDG and 68 Ga-FAPI PET/CT.
36. 18F-FDG Versus 68Ga-FAPI PET/CT in Visualizing Primary Hepatic Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue.
37. 68Ga-Exendin-4 PET/CT Differentiates Insulinoma From Accessory Spleen in a Patient Presenting Indeterminate MRI and 68Ga-DOTATATE PET/CT Findings.
38. 68 Ga-DOTATATE PET/CT in Primary Pulmonary Lymphoepithelioma-Like Carcinoma.
39. 18F-FDG Versus 68Ga-FAPI PET/CT in Visualizing Primary Hepatic Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue
40. 68Ga-FAPI PET/CT detected non-FDG-avid bone metastases in breast cancer.
41. [68Ga]Ga-FAPI PET/CT imaging of brown tumors in a patient with primary hyperparathyroidism.
42. Increased [68 Ga]Ga-FAPI uptake in focal nodular hyperplasia in a patient with sigmoid colon cancer.
43. Fibroblast Activation Protein-Targeted PET/CT with 18 F-Fibroblast Activation Protein Inhibitor-74 for Evaluation of Gastrointestinal Cancer: Comparison with 18 F-FDG PET/CT.
44. Acute Appendicitis Complicated by Septic Thrombophlebitis of the Portal Vein Shown by 18 F-FDG and 68 Ga-FAPI-46 PET/CT.
45. PET Imaging of Fibroblast Activation Protein in Various Types of Cancer Using 68 Ga-FAP-2286: Comparison with 18 F-FDG and 68 Ga-FAPI-46 in a Single-Center, Prospective Study.
46. 68Ga-Exendin-4 PET/CT Differentiates Insulinoma From Accessory Spleen in a Patient Presenting Indeterminate MRI and 68Ga-DOTATATE PET/CT Findings.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.